Bouchard J F, Lamontagne D
Faculté de Pharmacie, Université de Montréal, Quebec, Canada.
Am J Physiol. 1996 Nov;271(5 Pt 2):H1801-6. doi: 10.1152/ajpheart.1996.271.5.H1801.
The aim of this study was to assess whether the cardioprotective effect of ischemic preconditioning (IPC) on endothelial function in resistance coronary arteries of the rat involves adenosine and/or activation of ATP-sensitive K+ channels (KATP channels). Isolated rat hearts perfused under constant-flow conditions were exposed to 30 min of partial ischemia (flow rate 1 ml/min) followed by 20 min of reperfusion. Preconditioning was performed with 5 min of ischemia and 10 min of reperfusion before the 30-min ischemia. After the 20-min reperfusion period, coronary arteries were precontracted with U-46619 (0.1 microM), and the coronary response to the endothelium-dependent vasodilator serotonin (5-HT; 10 microM) was compared with that of the endothelium-independent vasodilator sodium nitroprusside (SNP; 3 microM). KATP channels or adenosine receptors were blocked with perfusion of either glibenclamide (0.3 microM) or 8-phenyltheophylline (8-PT; 5 microM), respectively, starting 15 min before IPC or a corresponding sham period. In untreated hearts, ischemia selectively diminished 5-HT-induced vasodilation, compared with sham hearts (without ischemia). The vasodilation by SNP was unaffected after ischemia and reperfusion. Preconditioning in untreated hearts preserved the vasodilation produced by 5-HT. Treatment of hearts with either glibenclamide or 8-PT halved the vasodilation produced by both 5-HT and SNP in sham hearts. Glibenclamide reduced by one-half, whereas 8-PT completely blocked, the protective effect of IPC on endothelium-dependent vasodilation. These results suggest that IPC affords protection to endothelial function in resistance coronary arteries of the rat partially by activation of KATP channels. Adenosine plays a major role in that protection.
本研究的目的是评估缺血预处理(IPC)对大鼠阻力冠状动脉内皮功能的心脏保护作用是否涉及腺苷和/或ATP敏感性钾通道(KATP通道)的激活。在恒流条件下灌注的离体大鼠心脏先经历30分钟的部分缺血(流速1毫升/分钟),随后再灌注20分钟。预处理是在30分钟缺血之前进行5分钟缺血和10分钟再灌注。在20分钟再灌注期后,用U-46619(0.1微摩尔)使冠状动脉预收缩,并将冠状动脉对内皮依赖性血管舒张剂5-羟色胺(5-HT;10微摩尔)的反应与内皮非依赖性血管舒张剂硝普钠(SNP;3微摩尔)的反应进行比较。从IPC或相应假手术期前15分钟开始,分别用格列本脲(0.3微摩尔)或8-苯基茶碱(8-PT;5微摩尔)灌注来阻断KATP通道或腺苷受体。在未处理的心脏中,与假手术心脏(无缺血)相比,缺血选择性地减弱了5-HT诱导的血管舒张。缺血和再灌注后,SNP引起的血管舒张未受影响。未处理心脏中的预处理保留了5-HT产生的血管舒张作用。在假手术心脏中,用格列本脲或8-PT处理心脏会使5-HT和SNP产生的血管舒张作用减半。格列本脲使IPC对内皮依赖性血管舒张的保护作用降低一半,而8-PT则完全阻断了该保护作用。这些结果表明,IPC对大鼠阻力冠状动脉内皮功能的保护作用部分是通过激活KATP通道实现。腺苷在该保护作用中起主要作用。